of (South). RATIONALE: Allergen-specific immunotherapy (AIT) is the only curative option of allergic diseases. However, a few proportions of allergic patients take AIT because of undesirable perspectives. In this multicenter cross-sectional study, we aimed to explore the patients' and doctors' perspectives of AIT through personal survey. METHODS: Allergic patients who took AIT were included to answer the survey developed by an expert panel of allergen and immunotherapy workgroup in Korea. The questionnaire consisted of 10 items to patients about demographics, perceptions, expectations, side-effects and satisfaction and 17 items to doctors about each patients' allergic status, used AIT products, disease severity changes based on guidelines, and medication changes after AIT. RESULTS: Total 267 patients completed the survey. Their mean duration of AIT was 27.3615.0 months, and the most prevalent disease was allergic rhinitis (91.4%) followed by asthma (42.7%) and atopic dermatitis (20.2%). Overall satisfaction rates of AIT in asthma and rhinitis were 85.3% and 86.4%, respectively. Asthma severity was dramatically decreased after AIT (intermittent 7.9% to 63.4%, mild persistent 38.6% to 28.7%, moderate persistent 46.5% to 6.9%, and severe persistent 6.9% to 1%). That of allergic rhinitis was also similar pattern (mild intermittent 0% to 64.8%, moderate-severe intermittent 8% to 20.2%, mild persistent 10.8% to 14.1%, and moderate-severe persistent 81.2% to 0.9%). The prescriptions of medication were much reduced in every drug class (corticosteroid, antihistamine and leukotriene receptor antagonist) after AIT. CONCLUSIONS: AIT is a very effective treatment method and can reduce disease severity as well as medication use with excellent satisfaction to patients.
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Efficacy of a quail eggs-based dietary supplement for allergic rhinitis Ekaterini I. Syrigou, PhD 1 , Fotios Psarros, MD 2 , Michail Makris 3 , Dimitra Grapsa 4 , and Konstantinos Syrigos 4 ; 1 Allergy Department Sotiria General Hospital, Athens, Greece, 2 Hellenic Navy Hospital, Athens, Greece, 3 ATTIKON HOSPITAL, Athens, Greece, 4 Athens School of Medicine, Athens, Greece. RATIONALE: We herein aimed to investigate the efficacy and safety of a dietary supplement, comprising the natural bioactive ingredients of quail eggs and the zinc mineral, in adult patients with active AR. METHODS: Adult patients, aged 18 to 60 years, with active symptoms of mild and intermittent AR, not receiving any other anti-allergic treatment and in good general health, were eligible for enrolment in this multi-center, single-arm, open-label trial. Objective and subjective responses to the study product were assessed based on peak nasal inspiratory flow (PNIF) measurements and self-rating of AR associated symptoms on a Visual Analogue Scale (VAS). The primary efficacy endpoint was patient's response as measured by PNIF values at 15, 30, 60, 90 and 120 minutes following administration of an oral dose (two tablets) of the study product. RESULTS: PNIF values gradually increased from baseline (pre-treatment), following oral consumption of the study product, with statistical significance first reached minutes later (p50.002). VAS scores for all AR symptoms gradually decreased from baseline, with statistical significance first reached at 15 minutes (rhinorrhea, p50.042; itchy nose, p50.001; sneezing p<0.001), 30 minutes (nasal congestion, p<0.001; itchy eyes, p50.003) or 60 minutes (watery eyes, p50.04). CONCLUSIONS: Our study results support the efficacy, rapid mode of action and excellent tolerability of the investigated product for symptomatic treatment of mild intermittent AR. These data warrant confirmation in further randomized placebo-controlled trials.
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Factors influencing Skin Prick Test Positivity in an Inner-City Pediatric Cohort (2013) (2014) (2015) (2016) Deepti Vellaichamy Manian, MD, Sairaman Nagarajan, MD, MPH, Sarah Schmitz, MD, and Maria-Anna Vastardi, MD; SUNY Downstate Medical Center, Brooklyn, NY. RATIONALE: There continues to be a nationwide increase in atopy in children, while obesity rates appear to have plateaued. This study examined the influence of adiposity and other factors on skin prick test (SPT) reactivity amongst inner-city children.
METHODS:
We conducted a retrospective cohort study in 88 children aged 1-19 on whom SPT to aero/food allergens was available. Adiposity and SPT-positivity were examined in relation to demographics/atopic conditions. Body mass index (BMI) percentiles, histories of food allergy (FA), allergic rhinitis (AR), asthma (AS) and atopic dermatitis (AD) were obtained. Pearson/Spearman correlation-matrices and chi-square tests were conducted using SPSS v21. RESULTS: In our population, 19% were obese and 51% were female. We found AR in 75%, AS 40%, FA 47% and AD 43% of our children. 51% SPT-positivity was indoor, 35% outdoor, 56% overall aero-allergen and 18% food allergens. Obesity was correlated with indoor and aero-allergen positivity (r50.19 p50.07). BMI was positively correlated with histamine response (r50.49 p50.02), BMI percentile with wheal sizes of cat (r50.24 p50.04), cockroach (r50.18 p50.1) but negatively with casein (r5-0.98 p50.1) and mixed-fish (r5-0.83, p50.03). Age was correlated with cockroach (r50.32 p50.006). AR was correlated with AS (r50.25 p50.01) and AD (r50.23 p50.02), as were FA and AD (r50.29 p50.006). AR and aero-allergen positivity were correlated (r50.29 p50.006), but not FA and food allergen positivity (r50.15 p50.16). CONCLUSIONS: Adiposity and SPT-reactivity were positively correlated in inner-city children, particularly to overall aero-allergens/indoor allergens. Children with AR showed aero-allergen SPT-positivity, while those with FA did not show food SPT-positivity.
